Browse by Poster Title

• V
• P5405
  Vaccination Prevalence in Patients With Inflammatory Bowel Disease: A Community Hospital Perspective
• P4934
  VACStent for Gastrointestinal Leaks: A Systematic Review and Meta-Analysis of Clinical Outcomes
• P3603
  Vagal Nerve Injury as a Complication of Transoral Incisionless Fundoplication

  
• P6229
  Vagal Nerve Stimulation-Induced Gastrointestinal Dysmotility and Megaduodenum: A Case of Intractable Nausea and Vomiting Resolved by Device Deactivation
• P3295
  Validating Calibration of an Artificial Intelligence Assessment of Endoscopic Severity in Ulcerative Colitis
• P4768
  Validation of a Colorectal Cancer Risk Prediction Tool Using 2 Large National Cohorts

  
• P1176
  Validation of a Logic Formula to Identify Strictures Among Crohn’s Disease Patients Using CONSTRICT Criteria
• P0863
  Validation of a Novel Colonoscopy Simulator for Distinguishing Novice, Intermediate, and Expert Endoscopists
• P4178
  Validation of ASGE Guidelines 2025 on the Modality of Gastrostomy Feeding Placement in Patients with Malignant Dysphagia
• P0289
  Validation of Colonic Volume Measurement by Scintigraphy Compared to Computed Tomography
• P0076
  Validation of ICD-10-CM Diagnosis Codes for Primary Sclerosing Cholangitis

  
• P3624
  Validation of NAFLD ICD Codes to Identify MASLD in a High-Risk Hispanic Population

  
• P1675
  Validation of S-WAVE Elasticity and ACE Attenuation Against MRE and MRI-PDFF in Patients with Clinically Diagnosed MASLD or MASH
• P1771
  Valproic Acid–Induced Liver Failure in a Patient With POLG-Related Disorder: A Case Emphasizing Early Diagnosis and Injury Pattern Recognition
• P3865
  Vanishing Act: Spontaneous Regression of HCC After Starting HCV Treatment and Emergent TIPS Placement

  
• P0219
  Vanishing Bile Duct Syndrome Following Cholecystectomy and ERCP: A Complex Case of Drug-Induced Cholestatic Liver Injury
• P3867
  Vanishing Bile Duct Syndrome Following Oxaliplatin-Based Chemotherapy: A Rare Hepatotoxic Complication

  
• P1798
  Vanishing Bile Duct Syndrome in the Setting of Valproic Acid Use: A Case Report of Progressive Ductopenia
• P0203
  Vanishing Bile Duct Syndrome: A Case Report
• P5585
  Variable Adherence to the Accepted Definition of a Probiotic and Recommended Criteria for Probiotic Characterization in Highly Cited Clinical Trials
• P0960
  Variant Mechanism in the Development of an Aorto-esophageal Fistula
• P4504
  Vascular Coil Migration: A Rare Cause of Post-Embolization Biliary Obstruction and Cholangitis
• P1228
  Vedolizumab as a Second Line Biologic for Cronkhite-Canada Syndrome
• P2538
  Vedolizumab as an Effective Therapy in the Treatment of Cronkhite-Canada Syndrome Refractory to Standard Medical Therapy: A Case Report
• P3243
  Vedolizumab Demonstrated Effectiveness in Improving Symptom Relief and Quality of Life in Chinese Patients With Ulcerative Colitis: Results from the Real-World VALUE Study
• P3242
  Vedolizumab Demonstrated Significant Improvements in Symptomatic Relief and Quality of Life in Patients With Crohn’s Disease: Results from VALUE, a Prospective, Multicenter, Observational Study
• P4146
  Vedolizumab for Severe Refractory Acute Cellular Rejection After Intestinal Transplantation

  
• P1264
  Vedolizumab for Ulcerative Colitis After Treatment of Isolated Rectal Diffuse Large B-Cell Lymphoma
• P5549
  Vedolizumab-Associated Acute Pancreatitis After 5 Years of Use in a Patient With Ulcerative Colitis
• P5522
  Vedolizumab-Induced Remission in Adult-Onset Autoimmune Enteropathy Complicated by Fibrotic Stricture

  
• P1211
  Venous Thromboembolism in Patients With Inflammatory Bowel Disease: An Analysis by Severity of Illness Using 2020 National Inpatient Sample Database

  
• P4411
  Very Important Perpetrator: A Patient with Chronic Secretory Diarrhea
• P4626
  Vibrating Capsules: Revolutionizing Constipation Management or Just a Shaky Gimmick?
• P2600
  Villous Volcano: An Atypical Presentation of the Volcano Sign
• P5635
  Viral Sabotage: HBV Reactivation in the Shadow of HIV
• P1204
  Virtual EUA Boosts Clinical Confidence in Complex Perianal Crohn’s Disease
• P1152
  Virtual Multidisciplinary Clinic Improves IBD Patient Engagement, Satisfaction, and Symptoms at Reduced Costs and Healthcare Utilization: A Propensity-Matched Prospective Observational Study

  
• P1930
  Virtual Multidisciplinary GI Clinic Improves Outcomes in Medicare-Aged Patients With Gastrointestinal Conditions

  
• P4818
  Virtual Reality as a Non-Pharmacologic Adjunct for Pain and Anxiety During an Unsedated Colonoscopy: Case Report
• P4835
  Visceral Fat Reduction via Palatable Elemental Diet Is Linked to Microbial and Hormonal Shifts in Adults
• P1790
  Visceral Kaposi Sarcoma of the Liver and Stomach Without Cutaneous Involvement in a Patient with HIV/AIDS
• P0568
  Vitamin A and Zinc Deficiencies Correlate with More Progressive Disease in Veterans with Advanced Liver Disease

  
• P3326
  Vitamin A Deficiency in IBD: A Large-Scale Population-Based Analysis
• P5326
  Vitamin C Deficiency in Patients with IBD: Prevalence and Associations With Other Micronutrient Deficiencies
• P3124
  Vitamin K Deficiency Secondary to Celiac Disease: A Rare Cause of Spontaneous Bleeding and Coagulopathy
• P0765
  Vocal Cord Paralysis as an Initial Presentation of Metastatic Esophageal Adenocarcinoma
• P2509
  Volvulus With a Twist: A Case of Domestic Body Retrieval
• P5104
  Vomiting and Vitamin Deficient: A Case of Wernicke's Encephalopathy Secondary to Cannabinoid Hyperemesis Syndrome
• P0879
  Vonaprazan Therapy Associated With Eradication of a Refractory Anastomotic Ulcer With Stricture After Gastric Bypass
• P3086
  Vonoprazan as Salvage Therapy in Recalcitrant Gastro-Jejunal Marginal Ulcer
• P2918
  Vonoprazan for Functional Dyspepsia: Systematic Review and Meta-Analysis
• P3798
  Vonoprazan Is Associated With a Lower Risk of Infections, Hospitalizations, and Death Compared to PPIs in Patients With Cirrhosis
• P2810
  Vonoprazan Use Is Associated With Lower Hospitalization and Bleeding Rates in Patients With Erosive Esophagitis Compared to Proton Pump Inhibitors: A Multinational Real-World Analysis
• P5219
  Vonoprazan Versus Proton Pump Inhibitors for Gastroprotection in Anticoagulated Patients: Real-World Outcomes From a Propensity-Matched Cohort Study